What is Re2O?
Re2O is a next-generation injectable formulated with ECM (Extracellular Matrix) components, including collagen, elastin and GAGs.
Unlike conventional skin boosters that focus on stimulating collagen production, Re2O takes a different approach by delivering key structural components found naturally within the skin.
With an ECM composition containing 89% collagen, Re2O is designed to support the skin’s structural environment and improve overall skin quality, texture and elasticity.
Elravie Re2O
Elravie Re2O is a next-generation skin booster made from hADM (human acellular dermal matrix) derived from human skin, containing ECM components naturally found in the skin.
What is hADM?
Human acellular dermal matrix is created by removing cells from donated human skin tissue while preserving key extracellular matrix (ECM) components, including collagen and elastin.
​
It acts as a scaffold that supports new cell growth and vascularisation, helping create an environment for natural tissue regeneration and repair.
The Cause of Skin Ageing:
ECM Depletion
Depletion of ECM Components, Including Collagen and Elastin
Reduced Collagen Synthesis, Dermal Density and Skin Elasticity
Development of Wrinkles, Enlarged Pores and Skin Dryness
What is ECM (Extracellular Matrix)?
• A 3D network of collagen, elastin and hyaluronic acid that supports the skin.
• Provides structure and support for healthy skin function.
• Healthy ageing requires more than surface care. Restoring ECM helps support skin structure and regeneration.
Epidermis
Dermis
Subcutaneous layer
Collagen
Elastin
Fibronectin
Growth Factors
The Next Generation of ECM Boosters
A new approach in aesthetic medicine, delivering Real Human Skin ECM to address the underlying causes of skin ageing.
How Elravie Re2O Works
Elravie Re2O contains key ECM components that support cell growth and tissue remodelling.
It provides an immediate subtle volumising effect after injection, while supporting new collagen formation over time for overall skin improvement.
Elravie Re2O Manufacturing Process
• Manufactured in accordance with guidelines from both the American Association of Tissue Banks (AATB) and the Korean Ministry of Food and Drug Safety (MFDS).
• Donor eligibility is carefully assessed through medical history, cause of death, blood testing and viral screening to ensure safety.
• Regular safety and efficacy testing is conducted for potential contaminants, including residual cellular material.
Safety of Elravie Re2O Raw Materials
Certified to Rigorous Safety Standards
AATB Accredited
• The AATB establishes standards for the safety, quality and ethical management of human tissue transplantation.
• Standards cover donor screening, infectious disease testing, tissue processing, sterilisation, quality control and traceability.
• Donors undergo a multi-step evaluation, including medical and social history, cause of death and infectious disease screening.
FDA-Compliant Raw Materials
Human tissue sourced from FDA-compliant U.S. tissue banks is used as the raw material.
MFDS Approved
The manufacturer of Elravie Re2O undergoes regular inspections and comprehensive evaluation by the Korean Ministry of Food and Drug Safety (MFDS), including Good Tissue Practice (GTP), manufacturing processes and quality control.
Re2O Before & After
At The Lab Clinic, every Elravie Re2O treatment begins with a personalised one-on-one consultation. Our clinician will assess your skin condition, areas of concern, and treatment goals to determine whether Re2O is suitable for you. A tailored treatment plan will then be created based on your individual skin needs, with a focus on supporting skin structure, quality, and natural tissue regeneration.
Re2O PRICELIST